tiprankstipranks
Advertisement
Advertisement

LSTA Stock Latest News

Lisata Therapeutics Amends Kuva Labs Merger Agreement Timeline
Company AnnouncementsLisata Therapeutics Amends Kuva Labs Merger Agreement Timeline
3d ago
8K
LSTA
Lisata Therapeutics extends deadline for Kuva tender offer
PremiumCompany Announcements
Lisata Therapeutics extends deadline for Kuva tender offer
21d ago
8K
LSTA
Lisata Therapeutics Delays Tender Offer Launch in Merger
PremiumCompany Announcements
Lisata Therapeutics Delays Tender Offer Launch in Merger
1M ago
8K
LSTA
Lisata Therapeutics to Be Acquired by Kuva Labs
PremiumCompany Announcements
Lisata Therapeutics to Be Acquired by Kuva Labs
2M ago
8K
LSTA
Lisata Therapeutics to be acquired by Kuva Labs for $5 per share cash plus CVR
PremiumThe Fly
Lisata Therapeutics to be acquired by Kuva Labs for $5 per share cash plus CVR
2M ago
LSTA
Lisata Extends Kuva Labs Acquisition Term Sheet Timeline
PremiumCompany AnnouncementsLisata Extends Kuva Labs Acquisition Term Sheet Timeline
2M ago
8K
LSTA
Is LSTA a Buy, Before Earnings?
Premium
Pre-Earnings
Is LSTA a Buy, Before Earnings?
2M ago
LSTA
Lisata Therapeutics ends Qilu certepetide collaboration deal
Premium
Company Announcements
Lisata Therapeutics ends Qilu certepetide collaboration deal
3M ago
8K
LSTA
Lisata Therapeutics announces mutual termination of license agreement with Qilu
PremiumThe Fly
Lisata Therapeutics announces mutual termination of license agreement with Qilu
3M ago
LSTA
Lisata Therapeutics Agrees to All-Cash Acquisition by Kuva
PremiumCompany Announcements
Lisata Therapeutics Agrees to All-Cash Acquisition by Kuva
4M ago
8K
LSTA
Lisata Therapeutics downgraded to Hold from Buy at Brookline
PremiumThe Fly
Lisata Therapeutics downgraded to Hold from Buy at Brookline
4M ago
LSTA
Lisata Therapeutics to be acquired by Kuva Labs for $4.00 per share
PremiumThe Fly
Lisata Therapeutics to be acquired by Kuva Labs for $4.00 per share
4M ago
LSTA
Lisata Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsLisata Therapeutics’ Earnings Call: Progress Amid Challenges
6M ago
LSTA
Lisata Therapeutics Reports Positive Q3 2025 Results
Premium
Company Announcements
Lisata Therapeutics Reports Positive Q3 2025 Results
6M ago
LSTA
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
Premium
Company Announcements
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
6M ago
8K
LSTA
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
PremiumThe Fly
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
6M ago
LSTA
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
LSTA
Lisata Therapeutics Highlights Cancer Therapy Innovations
PremiumCompany Announcements
Lisata Therapeutics Highlights Cancer Therapy Innovations
7M ago
8K
LSTA
VTI ETF News, 10/10/2025
PremiumMarket News
VTI ETF News, 10/10/2025
7M ago
LVO
VTI
Lisata Therapeutics Signs License Agreement with Catalent
PremiumCompany AnnouncementsLisata Therapeutics Signs License Agreement with Catalent
7M ago
8K
LSTA
Lisata Therapeutics, Catalent announce global ADC licensing agreement
Premium
The Fly
Lisata Therapeutics, Catalent announce global ADC licensing agreement
7M ago
LSTA
Lisata Therapeutics announces results from pancreatic cancer cohort of CENDIFOX
Premium
The Fly
Lisata Therapeutics announces results from pancreatic cancer cohort of CENDIFOX
7M ago
LSTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >